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By yeast two-hybrid screening using the calcium-binding protein ALG-2 as bait a new target of ALG-2 was identified, the RNA-binding
protein RBM22. In order to confirm these interactions in vivo we prepared fluorescent constructs by using the monomeric red fluorescent protein
to label ALG-2 and the enhanced green fluorescent protein to label RBM22. Confocal microscopy of NIH 3T3 cells transfected with either ALG-2
or RBM22 expression constructs encoding fluorescent fusion proteins alone revealed that the majority of ALG-2 was localized in the cytoplasm
whereas RBM22 was located in the nucleus. When cells were co-transfected with expression vectors encoding both fusion proteins ALG-2 was
found in the nucleus indicating that RBM22 which can shuttle between the cytoplasm and the nucleus may play a role in nuclear translocation of
ALG-2. Using zebrafish as a model mRNA homologues of ALG-2 and RBM22 were microinjected into the blastodisc-yolk margin of zebrafish
embryos at the 1-cell stage followed by monitoring the fusion proteins during development of the zebrafish. Hereby, we observed that ALG-2
alone evenly distributed within the cell, whereas in the presence of RBM22 the two proteins co-localized within the nucleus. More than 95% of the
two proteins co-localized within the same area in the nucleus suggesting a functional interaction between the Ca2+-signaling protein ALG-2 and
the RNA-binding protein RBM22.
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The pivotal role of Ca2+ as a general regulator of cellular
functions is made possible due to the tightly controlled steep
concentration gradient of ionized Ca2+ across cellular mem-
branes. If a cell becomes activated due to an external signal this
often results in up to a 100-fold rise in the intracellular free Ca2+
concentration due to the uptake of extracellular Ca2+ and/or the
release of Ca2+ from intracellular stores. These changes of the⁎ Corresponding author. Department of NMR-based Structural Biology, Max
Planck Institute for Biophysical Chemistry, Göttingen, Germany. Tel.: +49 551
2012200; fax: +49 551 2012202.
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doi:10.1016/j.bbamcr.2006.09.003free Ca2+ concentration can cause significant oscillations of Ca2+
in the cytosol as well as in the nucleus providing the possibility of
signal transduction for a number of different cellular activities
such as metabolism, protein phosphorylation and dephosphor-
ylation, fertilization, cell proliferation, division, gene expression
and apoptosis, to name a few (for a recent review see Ref. [1]).
Many of these functions are accomplished through the interac-
tion of Ca2+ with specific proteins resulting in modulations of
protein–protein interactions due to conformational changes of
the Ca2+-receptors.
During our studies on the role of the Ca2+-binding protein
ALG-2 [2,3] we identified a new protein interacting with ALG-
2 using a yeast two-hybrid screening. This protein was an RNA-
binding protein of unknown function [3] named RBM22
according to the GenBank (Accession No. NP_060517 for
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had been identified by others before. RBM22 contains a
conserved RNA-binding domain, a zinc finger of the unusual
type C-x8-C-x5-C-x3-H, and the C-terminus is unusually rich in
the amino acids Gly and Pro, including sequences of
tetraprolins. The protein is highly conserved among inverte-
brates and vertebrates. A homolog containing the RNA-binding
domain has also been found in yeast, and named either slt11 [6]
or ECM2 (YBR065c; [7]) which was identified as a splicing
factor involved in the activation and the assembly of the
spliceosome [6]. Fig. 1 shows the aligned sequences of RBM22
of human, mouse, zebrafish, Drosophila, and C. elegans [8,9].
The recently completed nucleotide sequence of the human
genome [10,11] revealed the surprising result that the whole
genome only contained about 30,000 different genes, a number
well below the amount of different proteins identified in cells.
On the other hand, the high degree of proteomic complexity is
achieved due to the fact that a single gene can generate
structurally and functionally distinct protein isoforms due to
alternative splicing [12,13]. Thus, it has been found that 75% of
human genes are thought to encode at least two or more
alternatively spliced isoforms [14,15].
Constitutive and alternative splicing of pre-mRNAs are
complex processes which must be accomplished with high
precision which is reflected by the complex machinery involved
in splicing, the spliceosome, an organelle composed of over 100
different proteins [16,17] with a size in the order of 20 MDa
[18], i.e. 4–5 times the size of a ribosome [18]. However, the
way how the splicing process is controlled and regulated is
poorly understood. Thus, impaired splicing can lead to severe
cell damage and many diseases, including cancer [19]. Several
laboratories used genome wide screening to identify essential
proteins involved in the regulation of alternative splicing [20],
in cell cycle [21], in zebrafish development [22] and in heart
development of Drosophila [23]. All these studies identified
homologues of RBM22 as being essential genes.
Here we provide evidence for the cellular co-localization of
ALG-2 and RBM22 in tissue cultures and in zebrafish during
development by using fluorescent constructs of the two proteins
and confocal microscopy. The results indicate that due to the
presence of RBM22, a typical nuclear protein, the cytosolic
protein ALG-2 becomes translocated to the nucleus. These
findings suggest that the formation of complexes between ALG-
2 and RBM22 may thus play an important role in Ca2+-
dependent signaling influencing alternative splicing and cell
division during development.
2. Materials and methods
2.1. Yeast two-hybrid screening
The cDNA encoding the full length human ALG-2 was cloned into plasmid
plexA and then used as bait to screen a human peripheral blood cDNA library.
Yeast transformation using the yeast strain L40 and screening were performedFig. 1. Alignment of the amino acid sequences of RBM22 from various organisms
AAH80205; (3) Danio rerio NP_998379; (4) Drosophila melanogaster NP_649440.3
acids 225–300 (human or mouse). The cysteins and the histidine of the conserved zby DUAL Systems Biotech AG, Zurich. Putative positive clones were verified
by co-transformation with the bait plasmid into yeast, and their nucleotide
sequences were analyzed.
2.2. Plasmid construction
The expression vector containing cDNA encoding ALG2-RFP has been
generated by insertion of ALG-2 cDNA, obtained by PCR-driven amplification,
into the NheI and AgeI sites of pRFP-N1. This vector, encoding for a
monomeric variant of red fluorescent protein, was a generous gift from Dr. R. Y.
Tsien, San Diego, USA. The expression vector containing cDNA encoding
RBM22-GFP was generated by insertion of human RBM22 cDNA, obtained by
PCR, into the NheI and BamHI sites of pEGFP-N3 (Clontech).
2.3. Mammalian cell culture
NIH 3T3 cells were plated in 24-well plates onto 12 mm cover slips and
cultured at 37 °C and 5% CO2 in Dulbecco's modified Eagle's medium
(DMEM), containing 4.5 g/L D-glucose and 110 mg/L pyruvate, supplemen-
ted with 10% fetal calf serum, 2 mM glutamine and streptomycin/penicillin.
After 24 h the cells were transfected at 80–90% confluency using either Roti-
Fect (Roth) or lipofectamine according to the manufacturer's instructions.
Transfections were performed with the single construct (0.5 μg plasmid
DNA) or as co-transfections of the ALG-2 and the RBM22 expression
vectors encoding fusion proteins (each 0.5 μg plasmid DNA) as detailed in
Results. For confocal microscopy the cells were fixed with 3.7%
formaldehyde 24 to 48 h after transfection. Mounting on object slides was
performed with MOWIOL (10% (w/v) polyvinyl alcohol 4–88 (Fluka), 25%
(w/v) glycerol, 0.1 M Tris–HCl, pH 8.5). Images have been taken using the
confocal laser-scanning microscope LSM 5 from Zeiss (Carl Zeiss Canada
Ltd.).
2.4. Embryo collection
Zebrafish (Danio rerio), AB strain, were maintained on a 14 h light/10 h
dark cycle to stimulate spawning [24] and their fertilized eggs were collected as
described elsewhere [25]. Embryos were placed in a custom-designed holding/
imaging chamber [25], in 30% Danieau's solution (17.4 mM NaCl, 0.21 mM
KCl, 0.18 mM Ca(NO3)2, 0.12 mM MgSO4·7H2O, 1.5 mM HEPES, pH 7.2)
and maintained at ∼ 28.5 °C throughout development.
2.5. Preparation of pSP64TNE-zRBM22-EGFP,
pSP64TNE-zALG2-mRFP plasmids, and the control plasmids
pSP64TNE-EGFP and pSP64TNE-mRFP
For the pSP64TNE-zRBM22-EGFP and pSP64TNE-zALG2-mRFP plas-
mids, the zRBM22-EGFP and zALG2-mRFP fragments were amplified from
the pzRBM22-EGFP-N3 and pzALG2-mRFP-N1 plasmids, respectively using
the following oligonucleotide primers: (1) For the pSP64TNE-zRBM22-EGFP
plasmid, 5′-ACCAGCGGCCGCATGGCGACGTCTTT-3′ and 5′-ACCAGAA-
TTCTTACTTGTACAGCTC-3′, and (2) for the pSP64TNE-zALG2-pmRFP-
N1 plasmid, 5′-ACCAGCGGCCGCATGGCATATCATAA-3′ and 5′-ACCAG-
AATTCTTAGGCGCCGGTGGAGTGGC-3′. The fragments were then cloned
into the pSP64TNE plasmid [26] using Not1 and EcoRI.
For the control plasmids, pSP64TNE-EGFP and pSP64TNE-mRFP, the
EGFP and mRFP fragments were amplified from the pzRBM22-EGFP-N3 and
pzALG2-mRFP-N1 plasmids, respectively using the following oligonucleotide
primers: (1) For the pSP64TNE-EGFP, 5′-ACCAGCGGCCGCATG-
GCCTCCTCCGAGGAC-3′ and 5′-ACCAGAATTCTTAGGCGCCGG-
TGGAGTGGC-3′, and (2) for the pSP64TNE-mRFP, 5′-ACCAGCGGCCG-
CATGGTGAGCAAGG-3′ and 5′-ACCAGAATTCTTACTTGTACAGCTC-3′,
and then cloned into the pSP64TNE plasmid using Not1 and EcoRI.. Accession numbers of RBM22 sequences: (1) human NP_060517; (2) mouse
; (5) C. elegans NP_502014.2. The RNA-binding domain corresponds to amino
inc finger Cx8Cx5Cx3H are indicated by an asterisk.
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Table 1
ALG-2 targets selected by yeast two-hybrid screening with ALG-2 as bait
Clone No. Motif
Peflin 5 Penta EF-hand protein
ALG-2 3 Penta EF-hand protein
AIP-1 2 ALG-2 interacting protein
RBM22 2 RNA-binding protein containing
a zinc finger of type C3H (Cx7Cx5Cx3H)
Annexin VII 2 Membrane protein
Annexin XI 2 Membrane protein
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zALG2-mRFP-mRNA, EGFP-mRNA, mRFP-mRNA, and
microinjection
The pSP64TNE-zRBM22-EGFP, pSP64TNE-zALG2-mRFP, pSP64TNE-
EGFP and pSP64TNE-mRFP plasmids were linearized with Xba1. The
zRBM22-EGFP-mRNA, zALG2-mRFP-mRNA, EGFP-mRNA, mRFP-
mRNA were prepared and precipitated using the mMESSAGE mMACHINE®
sp6 Kit (Ambion) following the protocol recommended by the manufacturer.
Embryos were injected with ∼ 300 pg to 400 pg mRNA into the yolk at the
1-cell stage. The microinjection pipettes and pressure injection system used were
described previously [25]. Bright-field and fluorescence images of embryos at
the 256-cell, 12-somite, and 20-somite stages, were captured with a Nikon C1
scanning confocal system using Nikon Fluor 20x/0.5NA and Nikon Fluor 40x/
0.8NA water dipping objectives. EGFP fluorescence was captured using a
488 nm excitation filter and 515 to 530 (30-nm bandwidth) nm emission filter,
while mRFP fluorescence was captured using a 543 nm excitation filter and
570 nm (long pass) emission filter. The co-localization analysis of the embryo
that was co-injected with both zRBM22-EGFP-mRNA and the zALG2-mRFP-
mRNA was determined using the “Measure Colocalization” function in
Metamorph version 6.1 (Universal Imaging Corp., Downingtown, PA).
3. Results
ALG-2 was up-regulated in proliferating tissues [3,27]. To
further understand the biology of ALG-2 we set to identify
interacting targets of ALG-2. To date only a few partner proteins
for ALG-2 were reported, namely AIP-1 [4] for ALG2 inter-
acting protein 1 and Alix [5] for ALG2 interacting protein X
which are identical proteins. The other targets included annexin
VII, annexin XI [28] or HEED, the human embryonic ectoderm
development protein [29]. The latter may be of special interest
in the context described below. It was also reported that ALG-2
interacts with penta EF-Hand proteins like e.g. peflin to form
heterodimers [30]. To search for new targets of ALG-2 we
exploited a yeast two-hybrid screening on a human peripheral
blood cDNA library using the full length cDNA of human
ALG-2 as bait. After screening over 106 clones 50 positive
clones were identified that reacted positive after a second X-Gal
filter test only in the presence of the ALG-2-plexA fusion bait
using β-galactosidase as reporter. Fig. 2 shows a representative
filter test in which the identified clones selected by the yeastFig. 2. Bait dependency test. Using ALG-2 as bait and human peripheral blood cD
number of plasmids reacting positive after the second X-Gal filter test some w
b=transformation into L40+plexA-ALG-2. The identified proteins are indicated.
development of the blue color of the β-galactosidase test.two-hybrid screening are indicated. Fig. 2 lane a shows a
control using mock-transformed L40 yeast strains, lane b shows
positive clones using L40 yeast strains in the presence of the
fusion plasmid plexA-ALG-2. Table 1 lists the clones that were
selected at least twice in the screen of those 25 library plasmids
that were chosen for further analysis indicating that the
screening procedure identified a number of targets of ALG-2
which were described also by others and are a good positive
control of the screen.
In order to examine whether ALG-2 and RBM22 interacted
with each other inside cells we prepared cDNA constructs
encoding the two proteins fused to either enhanced green
fluorescent protein (EGFP) to label RBM22 or monomeric red
fluorescent protein (mRFP) to label ALG-2. Fusion between the
fluorescent proteins and the proteins of interest have been
arranged so that the fluorescent proteins were C-terminal to
ALG-2 or RBM22, respectively i.e. the appearance of
fluorescence within the cells indicated appropriate in frame
expression of the fused proteins. Fig. 3A shows NIH 3T3 cells
expressing the fusion protein ALG-2-mRFP whereas Fig. 3B
displays a NIH 3T3 cell expressing RBM22-EGFP. Fig. 3A
reveals a diffuse cytosolic localization of ALG-2-mRFP
indicating that fusion of mRFP to ALG-2 does not lead to a
translocation of the fused protein to the nucleus, an important
prerequisite for functional studies of a cytosolic protein. On the
other hand, RBM22 fused to EGFP was mainly found in the
nucleus (Fig. 3B) as could be expected from an RNA-binding
protein. However, if the two fusion proteins were co-expressedNA as library source more than 1 million yeast colonies were screened. Of the
ere retransformed into yeast strain L40. a=transformation into L40+plexA;
The blue crosses at the bottom of the 2 panels are positive controls for the
Fig. 3. Transfection of NIH 3T3 cells. The cells were transfected with expression
vectors containing cDNA encoding either ALG-2-mRFP (A), or RBM22-EGFP
(B). In (C), NIH 3T3 cells were co-transfected with ALG-2-mRFP and RBM22-
EGFP and images were either taken with the filter for red fluorescence (left,
excitation at 543 nm), green fluorescence (right, excitation at 488 nm) or merged
(lower image).
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found in the nucleus as indicated by merging the green and red
fluorescent images which lead to a mainly yellow coloredFig. 4. Control images for EGFP and mRFP during zebrafish embryo development. T
through F, E′ is a 2-fold magnification of E) have been microinjected at the 1-cell
developmental stages as indicated.nucleus (Fig. 3C). This result indicates that RBM22, which can
shuttle between the cytosol and the nucleus using transportin-1
(J. Krebs, R. Falchetto, U. Kutay, unpublished results), interacts
with ALG-2 intracellularly and assists in nuclear translocation
of ALG-2.
The zebrafish (Danio rerio) is an excellent model organism
to study physiological functions during development because of
its transparency permitting the application of optical methods,
especially fluorescence (see [31] for a recent review). Thus,
RNAs encoding the fluorescent constructs of RBM22-EGFP
and ALG2-mRFP using the zebrafish homologues of ALG-2
and RBM22, respectively, were microinjected into the yolk of
1-cell stage embryos, followed by confocal images capturing at
various time intervals. Fluorescent signals from both fluorescent
proteins could be observed as early as the 16-cell stage as can be
seen from Fig. 4. However, the level of fluorescence produced
by mRFP was much weaker than the corresponding signals of
EGFP. Fig. 4 shows representative images captured at different
time points after the 64-cell stage (2 h post fertilization; hpf) to
the shield stage (6 hpf), both fluorescent proteins were evenly
distributed throughout cells during development.
Fig. 5 shows images of a zebrafish embryo microinjected at
the 1-cell stage with RNA of the ALG2-mRFP construct. The
fluorescent signal was observed as early as the 16-cell stage
(not shown), the earliest stage shown in Fig. 5 represents the
64-cell stage, and the images are shown up to the shield stage
(6 hpf). ALG2-mRFP is distributed over whole cells, but some
protein accumulated within the nucleus from 1K-cell stagehe mRNAs of either EGFP (left series, A through G) or of mRFP (right series, A
stage of the embryo and confocal images have been captured at the different
Fig. 5. Confocal images of ALG2-mRFP during zebrafish embryo development. mRNA of ALG2-mRFP has been microinjected at the 1-cell stage of the embryo and
confocal images have been captured at the different stages of development as indicated (H′ is a 2-fold magnification of H).
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(see below).
If the RNA encoding RBM22-EGFP was microinjected into
zebrafish embryos at the 1-cell stage the fluorescent signals
could be observed from the 16-cell stage embryo onwards likeFig. 6. Confocal images of RBM22-EGFP during zebrafish embryo development. m
and confocal images have been captured at the different stages of development as ind
zebrafish embryo after 25 h of development, E is a 5-fold magnification of a somitein the controls (not shown). A representative fluorescent image
of a 256-cell stage embryo (2.5 hpf) is shown in Fig. 6A
indicating that at this stage RBM22-EGFP is distributed over
the whole cell, but the protein starts to accumulate in the nucleus
as documented as brighter spots within the nuclei. NuclearRNA of RBM22-EGFP has been microinjected at the 1-cell stage of the embryo
icated. D shows even distribution of RBM22-EGFP over the whole body of the
area of 6D.
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and C) including embryos at high (3.3 hpf) and at sphere
(4 hpf) stage, respectively, i.e. from high stage onwards
RBM22 is exclusively localized within the nucleus. Fig. 6D
provides evidence that RBM22-EGFP is distributed evenly
over the whole body of the embryo (shown at prim-6, i.e.
25 hpf stage), Fig. 6E is a 5-fold magnification of a somite
area in Fig. 6D.
Fig. 7 shows a time-dependent series of representative
images of zebrafish embryos that have been co-injected with
RNAs of ALG2-mRFP and RBM22-EGFP at the 1-cell stage.Fig. 7. Confocal images of co-injected ALG2-mRFP and RBM22-EGFP during zeb
been co-injected at the 1-cell stage of the embryo and confocal images have been capt
(green fluorescence) represents RBM22-EGFP, the middle row (red fluorescence) A
rows indicating the co-localization of the 2 proteins within the nucleus during zebraAt the 64-cell stage ALG2-mRFP was hardly observable (Fig.
7A), therefore merging the green fluorescence from RBM22-
EGFP with the red fluorescence from ALG2-mRFP resulted in a
green image at the bottom. However, as seen at the next stage,
i.e. 256-cell stage (Fig. 7B), ALG2-mRFP started to accumulate
in the nucleus indicating that the presence of RBM22 helps to
translocate ALG-2 into the nucleus as evidenced by the merging
of the two confocal images resulting in yellow colored nuclei at
the bottom of Fig. 7B. This observation was made through all
stages of the embryo development up to stage “shield” as shown
in Fig. 7J. By comparing the brightness of the yellow spots atrafish embryo development. mRNAs of ALG2-mRFP and RBM22-EGFP have
ured at the different developmental stages as indicated. The upper rows of images
LG2-mRFP and the lower row (yellow images) the merge of the upper 2 image
fish development.
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of the fluorescence increased indicating the efficiency of the
translocation of ALG-2 into the nucleus. Quantitation demon-
strated that – depending on the available resolution –more than
95% of the 2 proteins co-localized within the same area of the
nucleus indicating that they form a functional complex within
the nucleus.4. Discussion
In the present paper we demonstrate that the cytosolic protein
ALG-2 (Fig. 3A) translocates to the nucleus (Figs. 3C and 7) in
the presence of RBM22. This is shown by laser-scanning
confocal microscopy of NIH 3T3 cells (Fig. 3) or zebrafish
embryos during development (Fig. 7) expressing fluorescence
tagged ALG-2 and RBM22 either alone or together. Over-
expression of the 2 fluorescent constructs did not influence the
normal development of the zebrafish embryos. The transloca-
tion of ALG-2 into the nucleus could already be observed in
images of zebrafish embryos even if only ALG2-mRFP was
microinjected at the 1-cell stage (Fig. 5) indicating that the
endogenous presence of RBM22 was sufficient to assist in
translocating ALG-2 into the nucleus. This translocation was
not induced by the presence of the fluorescent proteins since
control experiments with the fluorescent proteins alone did not
provide any evidence for the accumulation of either protein
within the nucleus (Fig. 4). Nuclear translocation of ALG-2 was
earlier reported by Kitaura et al. [30] who detected ALG-2 in the
nuclei of Jurkat T-cells. This translocation of ALG-2 into the
nuclei of T-cells could be due to the interaction with RBM22
which is especially enriched in T-cells (J. Krebs, unpublished
observations).
It remains to be shown how the two proteins interact. In a
recent publication by Shibata et al. [32] the authors identified a
region in the amino acid sequence of Alix/AIP1 responsible for
the interaction with ALG-2. This part is rich in prolines and
contains four tandem-repeats of PxY that are crucial for the
interaction with ALG-2 as shown by replacement with alanines.
The C-terminal part of RBM22 is rich in prolines (including
several tetraprolin sequences) and glycines, and the N-terminal
region contains several PY or PF pairs, but how RBM22
interacts with ALG-2 has to await further experiments.
As shown in Fig. 1 RBM22 is a highly conserved RNA-
binding protein, the human and mouse proteins being identical.
Comparing the mammalian sequence with those of zebrafish,
Drosophila or C. elegans the homologies between these
proteins are 75% or better. If one compares the domain
structures, i.e. the RNA-binding domains or the unusual zinc
finger of the type Cx8Cx5Cx3H, the homologies are even
higher. On the other hand, in the yeast homologue slt11 [6,33]
or ECM2 [7] only the RNA-binding domain is conserved, but
the zinc finger types are different. These proteins have been
identified as splicing factors [6,33]. Rappsilber et al. [17] and
Makarova et al. [34] identified the mammalian homolog of
ECM2 (which is identical with RBM22) as a member of the
mammalian spliceosome.In a genome wide screening Graveley and co-workers
identified regulators of alternative splicing by RNA inter-
ference in Drosophila [20]. One of the identified regulators,
cg14641, is the Drosophila homolog of RBM22 responsible –
among others – for the regulation of exon 4 splicing of the
Dscam gene of Drosophila [20]. Alternative splicing, in
general, is regulated by proteins associating with the pre-
mRNA, and function either to enhance or to suppress the
ability of the spliceosome to recognize the splice site(s)
flanking the regulated exon. Kim et al. [23] while studying
genes essential for heart development in Drosophila reported
that cg14641 is one of those essential genes. In another study
Kittler et al. [21] identified genes essential for cell cycle
progression by an RNA interference screening of HeLa cells.
Among the described 37 genes required for cell division the
RBM22 homologue was identified next to other splicing
factors known to generate mitotic spindle defects if knocked
down. Finally, Hopkins' group reported that in a genome wide
insertional mutagenesis screening of early zebrafish develop-
ment 315 genes could be identified as being essential during
this period, all being highly conserved during evolution [22].
One of the identified genes is the zebrafish homologue of
RBM22. In all these investigations described before it became
evident that RBM22 may be involved in developmental
processes in which the regulation of alternative splicing of
cytoskeletal proteins could become important like in Droso-
phila for the Dscam gene which is essential for neuronal
outgrowth and target recognition [35]. Interestingly, another
target interacting with ALG-2, HEED [29], is a transcriptional
repressor involved in the regulation of homeotic genes during
mouse development [36]. In the future it will be important to
show how Ca2+-signaling could become involved in the
regulation of alternative splicing due to the interaction
between RBM22 and the Ca2+-binding protein ALG-2.
In conclusion, in the present paper we provided evidence for
the functional interaction between the Ca2+-binding protein
ALG-2 and the RNA-binding protein RBM22 in tissue cultures
as well as in zebrafish embryonal development. This may
provide a previously not described link between Ca2+-
controlled signaling and the regulation of alternative splicing
influencing basic cellular processes during development.
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